Tonghua Dongbao Pharmaceutical Co., Ltd.

Shanghai Stock Exchange 600867.SS

Tonghua Dongbao Pharmaceutical Co., Ltd. Revenue Per Share for the year ending December 31, 2023: USD 0.22

Tonghua Dongbao Pharmaceutical Co., Ltd. Revenue Per Share is USD 0.22 for the year ending December 31, 2023, a 7.12% change year over year. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.

Tonghua Dongbao Pharmaceutical Co., Ltd. Revenue Per Share for the year ending December 31, 2022 was USD 0.20, a -18.80% change year over year.
Tonghua Dongbao Pharmaceutical Co., Ltd. Revenue Per Share for the year ending December 31, 2021 was USD 0.25, a 14.79% change year over year.
Tonghua Dongbao Pharmaceutical Co., Ltd. Revenue Per Share for the year ending December 31, 2020 was USD 0.22, a 11.46% change year over year.
Tonghua Dongbao Pharmaceutical Co., Ltd. Revenue Per Share for the year ending December 31, 2019 was USD 0.20, a 2.72% change year over year.

Key data

Date	Revenue Per Share	Dividend Per Share	Free Cash Flow Per Share	Return on Assets (ROA)

Shanghai Stock Exchange: 600867.SS

Tonghua Dongbao Pharmaceutical Co., Ltd.

CEO	Mr. Sheng Leng Chun
IPO Date	Aug. 24, 1994
Location	China
Headquarters	Dongbao New Village
Employees	3,196
Sector	Healthcare
Industries Pharmaceuticals 3D Printing Biotechnology Composite Materials Drugstores & Retail Pharmacies Eyewear Non-Alcoholic Beverages Plastics

Description

Tonghua Dongbao Pharmaceutical Co., Ltd. researches and develops, manufactures, and sells pharmaceutical products for the treatment of diabetes and cardiovascular-based diseases in China. The company operates through Pharmaceutical Industry and Building Materials Industry segments. Its lead product portfolio includes insulin analogues, such as insulin glargine, Insulin aspart, and insulin lispro; antidiabetic drugs; and oral hypoglycemic drugs, as well as Gan Shulin pens, blood glucose meters, and other medical devices. It offers building materials. The company has a strategic alliance with Adocia. Tonghua Dongbao Pharmaceutical Co., Ltd. was founded in 1985 and is based in Tonghua, China.

Key trends

Past 5 years